26 min listen
News | Checkpoint inhibitors and COVID-19 mortality; HCC rates slow in cities, continue to climb in rural areas
FromBlood & Cancer
News | Checkpoint inhibitors and COVID-19 mortality; HCC rates slow in cities, continue to climb in rural areas
FromBlood & Cancer
ratings:
Length:
9 minutes
Released:
Dec 1, 2020
Format:
Podcast episode
Description
Blood & Cancer News Stories: Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest: https://bit.ly/2JlP2FN HCC rates slow in cities, continue to climb in rural areas: https://bit.ly/2Jx6Ux1 Risk factors for severe immune-related AEs identified: https://bit.ly/3fO6Fd8 Contact Blood & Cancer at podcasts@mdedge.com
Released:
Dec 1, 2020
Format:
Podcast episode
Titles in the series (100)
Sickle cell update: Treating pain and progress toward cure: When it comes to treating pain related to sickle cell disease, consider the underlying factors, from constipation to compression spine deformity. That’s just some of the advice from Ifeyinwa Osunkwo, MD, of Atrium Health and Levine Cancer Institute... by Blood & Cancer